Roquefort Therapeutics: Pioneering approach to cancer drawing interest from big pharma and private eq proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Roquefort Therapeutics PLC - London-based biotechnology company, focused on developing medicines for hard-to-treat cancers - Announces the development of new small interfering ribonucleic acid.
Roquefort Therapeutics PLC reported an increased loss for 2022 as costs rose in several areas, with the year including a successful acquisition, and said it expects to meet its targets for the current. | June 5, 2023